Last reviewed · How we verify
PF-07038124 ointment 0.01% (pf-07038124-ointment-0-01)
At a glance
| Generic name | pf-07038124-ointment-0-01 |
|---|---|
| Sponsor | Pfizer Inc. |
| Phase | Phase 2 |
Approved indications
Common side effects
- Dermatitis atopic
- Application site pruritus
- Pruritus
- SARS-CoV-2 test positive
- Nasopharyngitis
- Upper respiratory tract infection
- Urinary tract infection
- Muscle spasms
- Psoriasis
- Herpes zoster
- Muscle strain
- Blood glucose increased
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PF-07038124 ointment 0.01% CI brief — competitive landscape report
- PF-07038124 ointment 0.01% updates RSS · CI watch RSS
- Pfizer Inc. portfolio CI